Chemistry, structure & PK
MT-II is what you get when chemists take the active core of alpha-MSH, swap its weak points for durable ones, and clamp…
The ring that made a fragile hormone into a potent drug
MT-II is what you get when chemists take the active core of alpha-MSH, swap its weak points for durable ones, and clamp the chain into a ring. This unit shows that structure atom group by atom group, then follows the molecule through the body: how it is absorbed, how long it lasts, and what is genuinely unknown about its pharmacokinetics.
Understanding the chemistry explains both why MT-II works at tiny doses and why its real-world behavior, especially from nasal sprays, is far less predictable than vendors imply.
Key terms
The molecule, atom group by atom group
MT-II's formula is Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2: an acetyl cap, a norleucine, and then six building blocks (residues) clamped into a ring by a bridge between Asp and Lys. Click each part of the structure to see what it does and why it was chosen. Three deliberate design changes turn a fragile hormone fragment into a rugged drug.
The dashed bond is the heart of the design: a lactam bridge joining Asp and Lys that locks the chain into a ring. The ring freezes the molecule into the exact shape receptors recognize, so less energy is wasted and binding is stronger. Combined with the norleucine and D-phenylalanine swaps, the result is a peptide roughly 90 to 100 times more potent than the natural hormone in the classic lizard skin bioassay.
AdvancedThe three changes from alpha-MSH, and why each matters
First, Met to Nle removes a sulfur that oxidizes and inactivates the peptide. Second, L-Phe to D-Phe flips one residue to its mirror image, which enzymes cannot cleave and which boosts potency. Third, the Asp-Lys lactam ring constrains the backbone into the bioactive conformation. Each change trades the natural hormone's precision for durability and strength, and together they erase receptor selectivity, the price of making it so robust.